Registrations are being accepted for the 2015-2016 Sumner J. Yaffe Memorial Lecture Series, sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), in implementing the Best Pharmaceuticals for Children Act.
The series began in 2011 and is dedicated to the memory of Dr. Sumner J. Yaffe who is considered by many to be the father of pediatric clinical pharmacology. This interactive Webinar series focuses on topics relevant to pediatric clinical and developmental pharmacology.
The next lecture will be titled “Application of Metabolomics to Provide Pediatric Biomarkers” and will be presented by Dr. Susan Sumner from RTI International on Tuesday, January 12, 2016 from 12:00 p.m. – 1:15 p.m. U.S. Eastern Time.
This lecture will begin with a basic description of metabolomics, the technologies used for targeted and broad spectrum approaches, and provide information on study design considerations, and sample collection and storage considerations. The remainder of the presentation will provide results from several investigations that link perturbations in the metabotype of biological specimens with environmental exposure, birth outcomes, or early childhood development.
Please contact Dr. George Giacoia at firstname.lastname@example.org if you have any questions about the Webinar series. Contact email@example.com with any questions regarding registration.
*Returning Participants: If you have previously registered for a 2015-16 Sumner J. Yaffe Webinar, you will see the following message when you click ‘Register’: “To sign up for a lecture, enter your confirmation number below, click OK and then click the Modify tab on the left navigation.” Click the link to have your Confirmation Number sent to you, then proceed as instructed.
The tentative schedule of initial lectures in 2016 is below:
January 12, 2016 Application of Metabolomics to Provide Pediatric Biomarkers
February 23, 2016 Harmonization of Terminology for Biomarkers and Endpoints to Strengthen Quality and Improve Efficiency of Translational Science
National Cancer Institute
March 17, 2016 Pediatric Biomarkers and the Convergence of Academic and Regulatory Sciences
U.S. Food and Drug Administration
April 14, 2016 Biomarkers in Pediatrics: Children as Biomarker Orphans
Johns Hopkins University